TIVANTINIB, (+)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C23H19N3O2
Molecular Weight	369.4159
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O=C1NC(=O)[C@@H]([C@H]1C2=CNC3=C2C=CC=C3)C4=CN5CCCC6=CC=CC4=C56

InChI

InChIKey=UCEQXRCJXIVODC-WOJBJXKFSA-N

InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

TIVANTINIB, (+)-

Common Name

English

(3S,4S)-3-(5,6-DIHYDRO-4H-PYRROLO(3,2,1-IJ)QUINOLIN-1-YL)-4-(1H-INDOL-3-YL)-2,5-PYRROLIDINEDIONE

Preferred Name

English

2,5-PYRROLIDINEDIONE, 3-(5,6-DIHYDRO-4H-PYRROLO(3,2,1-IJ)QUINOLIN-1-YL)-4-(1H-INDOL-3-YL)-, (3S,4S)-

Systematic Name

English

Code System Code Type Description

FDA UNII

E9UU0ESM69

Created by admin on Tue Apr 01 20:54:24 GMT 2025 , Edited by admin on Tue Apr 01 20:54:24 GMT 2025

PRIMARY

EU-Orphan Drug

EU/3/09/678

Created by admin on Tue Apr 01 20:54:24 GMT 2025 , Edited by admin on Tue Apr 01 20:54:24 GMT 2025

PRIMARY

Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in January 2012 on request of the Sponsor.

CAS

905854-03-7

Created by admin on Tue Apr 01 20:54:24 GMT 2025 , Edited by admin on Tue Apr 01 20:54:24 GMT 2025

PRIMARY

PUBCHEM

11696354

Created by admin on Tue Apr 01 20:54:24 GMT 2025 , Edited by admin on Tue Apr 01 20:54:24 GMT 2025

PRIMARY

SUBSTANCE RECORD


					E9UU0ESM69

TIVANTINIB, (+)-